Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

SPDR Series Trust SPDR S&P Biotech ETF (NY: XBI )

87.15 +0.98 (+1.14%)
Official Closing Price Updated: 8:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,704,875
Open 86.78
Bid (Size) 87.20 (11)
Ask (Size) 87.21 (3)
Prev. Close 86.17
Today's Range 86.35 - 87.73
52wk Range 81.14 - 105.47
Shares Outstanding 665,000
Dividend Yield 0.03%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Healthcare Stocks Doing Well But SMID Biotech Looking A Little Frazzled
Small caps took another step down this past week as geopolitical events dampened sentiment. 
Via Talk Markets
Topics ETFs Stocks / Equities
SpringWorks Therapeutics Leads Biotech Pack In Weekly Retail Follower Surge: What's Fueling Interest?
Investor attention is now on whether Merck will confirm a formal offer as speculation over a potential acquisition continues dominating discussions around the stock. 
Via Stocktwits

Performance

YTD
-4.79%
-4.79%
1 Month
-3.53%
-3.53%
3 Month
-10.13%
-10.13%
6 Month
-11.88%
-11.88%
1 Year
-9.41%
-9.41%

More News

Read More
Healthcare Sector Trying To Bounce Back
Via Talk Markets
Topics ETFs Stocks / Equities
Capricor Therapeutics’ Retail Chatter Explodes On Stocktwits After FDA Grants Priority Review For DMD Therapy
Via Stocktwits
Exposures Product Safety
Is It Time To Shift Focus To Beaten-Down Healthcare Stocks As Volatility Soars?
Via Talk Markets
Topics ETFs Stocks / Equities
Biotech Rally Coming In Weeks Ahead?
Via Talk Markets
Topics ETFs Stocks / Equities
Emergent BioSolutions Stock Sinks As Q4 Revenue Plunges 30%, But Retail Clings To Profit Swing
Via Stocktwits
Adma Biologics' Retail Traders Eye Higher Open After Blowout Q4, Strong Full-Year Outlook
Via Stocktwits
Retail Bets TG Therapeutics Stock Can Sustain Post-Earnings Gains Throughout The Week
Via Stocktwits
Altimmune Retail Buzz Heats Up On MASH Progress, FDA Nod For New Trials: Stock Jumps After Q4 Print
Via Stocktwits
Exposures Product Safety
MannKind Stock Surges After-Hours On Q4 Revenue Beat, Debt Reduction As Retail Investors Celebrate ‘Amazing Comeback’
Via Stocktwits
Arcutis Biotherapeutics Sees 400% Spike In Retail Buzz As Q4 Beat Fuels After-Hours Rally
Via Stocktwits
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst
Via Benzinga
Ardelyx Stock Rises After-Hours On Q4 Beat, Drug Sales Outlook: Retail Gets Big Dose Of Optimism
Via Stocktwits
SpringWorks Therapeutics Gains Retail Interest Ahead Of Q4 Earnings – What Investors Expect
Via Stocktwits
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports
Via Benzinga
Topics ETFs Government World Trade
Exposures Political Tariff
Biotech Stocks Had A Good Week Despite Crosscurrents
Via Talk Markets
Topics ETFs Stocks / Equities
Travere Therapeutics Sparks Retail Frenzy As Stock Hits Over 2-Year High On FDA Approval Plan For Kidney-Disease Drug
Via Stocktwits
Exposures Product Safety
Healthcare And Biotech Playbook As Disruption Gathers Force
Via Talk Markets
Topics ETFs Stocks / Equities
Springworks Stock Soars To Nearly 3-Year High On Buyout Buzz, Retail Sentiment Rockets
Via Stocktwits
Viking Therapeutics Stock Down Over 20% In 2025: Retail Traders Predict Where It Could End The Year
Via Stocktwits
Small- To Mid-Cap Biotech Trades Poised For Gains
Via Talk Markets
Topics ETFs Stocks / Equities
Biogen Rises On FDA Nod for Alzheimer's Drug Dosing Regimen, But Sage Deal Fallout Irks Retail
Via Stocktwits
Exposures Product Safety
Intellia Stock Dips After Morgan Stanley Downgrade, Retail Sentiment Weakens
Via Stocktwits
Akero Stock Hits Over 18-Month High On MASH Trial Data: Citi Lauds ‘Best-Case Scenario,’ Retail Exuberant
Via Stocktwits
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.